A massive accumulation of neutrophils, mainly due to enhanced interleukin-8 (IL-8) levels, is believed to contribute to the deleterious effects of Pseudomonas aeruginosa lung infection, e.g., in cystic fibrosis (CF). Antibodies to phospholipase C, an exoenzyme of I! aeruginosa, are detected early and at high levels in CF patients. However, R aeruginosa produces at least two types of phospholipase C (PLC), one haemolytic (PLC-H) and the other non-haemolytic (PLC-N), both with mol. wts of c. 77 kDa. Experiments were performed to evaluate the potential contribution of R aeruginosa PLC to neutrophil accumulation during infection. Therefore, R aeruginosa PLC-H and PLC-N were compared' with regard to IL-8 generation from human monocytes. Purified PLC-H as well as culture supernates (rnol. wt > 50 kDa) of a R aeruginosa strain capable of producing both PLC-H and PLC-N, and mutant strains deficient in the production of one or other phospholipase, or both, were examined. Purified PLC-H (only at low concentrations up to 1 unit/4 X lo5 monocytes), induced a dose-dependent increase in IL-8 release and IL-8-specific mRNA expression over that of unstimulated cells (at 4-, 12-and 24-h incubation times). Higher concentrations of PLC-H led to a decrease in IL-8 release and IL-&specific' mRNA expression. These findings were confirmed by the results obtained with the supernates of cultures of mutant strains of R aeruginosa PA01 that produced either a PLC-H or PLC-N or neither. Stimulation and inhibition of IL-8 release and mRNA expression were associated with a culture supernate fraction of mol. wt > 50 kDa and containing PLC-H. These results contribute to the understanding of the role of both I! aeruginosa PLC in IL-8 generation during their interaction with human monocytes.
Introduction
Pseudomonas aeruginosa infections play an important role in bums and sepsis, as well as in cystic fibrosis (CF) [l-31. In contrast to acute l? aeruginosa infections in burned patients, CF patients become chronically colonised by I? aeruginosa [ 3 - 51. The pathogenesis of CF injury is associated with a massive accumulation of neutrophil granulocytes and neutroPhil-mediated chronic pulmonary inflammation and destruction [4, 6, 71 . Although elevated levels of leukotriene Bq -a potent chemotactic factor for neutrophils -have been found in the sputum of CF patients, it is now well established that the chemotactic cytokine l? aeruginosa produces various virulence factors. Phospholipase C, an exoenzyme of I? aeruginosa, has been identified as a critical component in the pathogenesis of l? aeruginosa infection [ 1 1 -131. Antibodies to phospholipase C are detected early and at high levels in CF patients [14, 151. However, I? aeruginosa produces at least two types of phospholipase C (PLC), one haemolytic (PLC-H) and the other non-haemolytic (PLC-N) [ 16-181. The PLC-H with a mol. wt of 77kDa haemolyses human and sheep erythrocytes and degrades not only phosphorylcholine but also sphingomyelin, which are key components of eukaryotic cell membranes. PLC-N, with a mol. wt of c. 78 kDa, is non-haemolytic for red blood ce1l.s and does not degrade sphingomyelin [ 16-181. Supernates of bacterial cultures of I? aeruginosa containing PLC induced the generation of the chemotactic active leukotriene B4 from human neutrophils and monocytes [2] . Similar results were obtained with partially purified PLC as described by Meyers et al. in in-vivo and in-vitro models [12] . The role of I? aeruginosa PLC in IL-8 generation has not been studied yet. Furthermore, previous studies did not distinguish between the two types of PLC with regard to their interaction with human effector cells. Current investigations regarding PLC activity by Pseudomonas have adopted a genetic approach. In this regard, the results of Graham et al. suggest that it is predominantly PLC-H that plays a role in the inflammation in the model of chronic lung infection in the rat [18, 191. Studies performed by Wiener-Kronish et al. with isogenic I? aeruginosa PA0 1 strains indicated that PLC is predominantly important in mediating injury to the alveolar epithelial barrier in acute I? aeruginosa pneumonia in rabbits [7] . PLC production enhanced virulence when tested in a model of burns in the mouse [7, 161.
The present study was designed to evaluate the relative inabilities of PLC-H and PLC-N to induce IL-8 release from human monocytes -the main producers of IL-8. The study used several previously characterised isogenic I? aeruginosa PA0 1 strains that were deficient in the production of either PLC-H or PLC-N, or both; purified haemolytic PLC from P aeruginosa was also used.
Materials and methods

Materials
Peptone, sodium metrizoate solution (75% w/v) and RPMI medium 1640 (no. 430-1800) were obtained from Gibco (Eggenstein, Germany). Additional chemicals were obtained from Sigma. The IL-8 antibodies were kindly provided by M. Ceska, Sandoz, Vienna, Austria.
Buffer
The buffer used for washing the peripheral blood mononuclear cells (PBMC) and monocytes was modified Dulbecco's phosphate-buffered saline (PBS) containing 137 mM NaCl, 8 mM NazHP04, 3 mM KCI and 3 mM KH2P04, pH 7.4. For stimulation assays the cells were suspended in RPMI 1640 medium supplemented with fetal calf serum (FCS) 10%.
Bacterial strains
The bacterial strains used in the study are listed in Table 1 . P aeruginosa PAOl, expressing both PLC-H and PLC-N, was used as the wild-type strain. The following mutants were used. I? aeruginosa PAOA SR is a deletion mutant that retains PLC-N when measured [20] to induce the synthesis of PLC. Bacterial cells were removed by centrifugation (5000 g, 10 min; Sorvall RC-SB, rotor SS34) and the supernate was filter sterilised. Twenty ml of the original culture supernate (100 mM HEPES, 500 mM NaCl, I mM CaC12, pH7.5) were concentrated to 2 ml; the original volume was made up with buffer and again concentrated. This procedure was carried out three times. The resulting solution was considered as 'undiluted'. To achieve the various culture supernate fractions concentrators (CentriplusTM, Amicon GmbH, Witten, Germany) with mol. wt cut-offs of 50, 30 and 5 kDa were used. The culture supernate above 50 kDa contained PLC activities as indicated in the Results section. The concentrated culture supernate fractions were stored at 4°C.
Preparation of pur$ed P aeruginosa PLC-H
PLC-H was produced for purification by overexpression of the plcH gene in a T7 expression system constructed for P aeruginosa [21] . Cultures of P aeruginosa ADD 1976 (pADD3268:plcH) were grown in brain-heart infusion media to an OD600 of c. 0. 
Enzyme assays
The activity of PLC was determined spectrophotometrically (OD420 nm) with p-nitrophenylphosphorylcholine as substrate [20] . One unit of activity (U) was defined as the amount of enzyme necessary to liberate 1 pmol of p-nitrophenol/min from p-nitrophenylphosphorylcholine at 37°C.
Preparation of monocytes
Human peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque sedimentation from venous blood anti-coagulated with ethylenediaminetetraacetic acid [22] . The isolated PBMC contained c. 15% monocytes as estimated by the non-specific esterase assay [23] . PBMC were incubated at a concentration of 1 X 107/ml at 37°C in air with C02 5% in plastic flasks (Costar) for 2 h. The adherent cells were collected and 95% of the cells were esterasepositive by the esterase assay according to the method of Tucker et al. [23] .
Cell viability
Cell viability was studied by trypan blue exclusion, by analysis of lactate dehydrogenease (LDH) release (Boehringer Mannheim, Mannheim, Germany), as well as by determination of mitochondria1 activity with WST-1 (Boehringer Mannheim) in stimulated and unstimulated cells. The assays were performed as described by the manufacturer. All cellular stimulation experiments were performed under conditions of concentration and time in which the viability of the monocytes in all three assay systems was > 80%.
Cell culture conditions
Monocytes were suspended in RPMI medium plus FCS 10% at a concentration of 4 X 105/ml. The cells were cultured in the presence of the appropriate stimulus for up to 24 h. Culture supernates were collected and analysed for their IL-8 content; cell pellets were analysed for IL-&specific mRNA expression.
IL-8 assay
IL-8 release was determined by a sandwich ELISA technique as described previously [24] . Briefly, each well of a 96-well plate (Nunc Maxisorb, Roskilde, Denmark) was pre-coated overnight at 4°C with 100 pl of Tween 20 0.1% in PBS containing a monoclonal anti-IL-8 antibody (subclone 4G9/A5/A7) at a concentration of 5 pglml. The plates were washed three times with PBS/Tween, the appropriate samples and the standard (a recombinant human TL-8; Calbiochem, Bad Soden, Germany) were added and incubation proceeded for 2 h at 37°C. Thereafter, polyclonal anti-IL-8 antibody labelled with alkaline phosphatase (3 pglml) was added. 
Results
Modulation of IL-8 synthesis by purijied PLC-H from I! aeruginosa
In a first set of experiments the capacity of purified PLC-H from F1 aeruginosa to modulate IL-8 release from human monocytes was examined. Human monocytes (4 X lo5) were stimulated with various concen- Fig. 3 shows the results after an incubation time of 24 h: only culture supernates expressing PLC-H (PAOl and PA01 PLCN") led to a decrease in IL-8 release (Fig. 3a) . In parallel to the decrease in IL-8 release a decrease in IL-%specific mRNA expression (Fig. 3b) was observed in the corresponding monocyte pellets. The decrease in IL-8 production was observed in a time-and dose-dependent manner. In this regard, culture supernates containing PLC-H at concentrations > 1 U (PAOl and PAOl PLCN") diminished spontaneous IL-8 release; 3 U PLC-H of PA01 PLCN" reduced release to 0.6 SD 0.3 ng/ml compared with 78 SD 12ng/ml from unstimulated cells. The inhibitory effects of PLC-H were observed after an incubation time of 4 h and were most pronounced after an incubation time of 24 h (Fig. 4) . The data are presented for l? aeruginosa PAOl in Fig. 4a and for I? aeruginosa PA01 PLCN" in Fig. 4b . In contrast to those containing PLC-H, culture supernates containing only PLC-N (PA01 ASR), even at the high concentration of 7 U, neither downregulated nor upregulated IL-8 release from human monocytes (data not shown). Culture supernates devoid of PLC activity (PAOlASRN) also failed to modulate IL-8 release (data not shown).
Modulation of IL-8 release from human monocytes after stimulation with different fractions of I! aeruginosa culture supernates
The ability of additional exoproducts of l? aeruginosa to modulate IL-8 release from human monocytes was tested. For this purpose total culture supernates from Fig. 5a ) and PA01 PLCN" (Fig. 5b ), but not from PAOlASR (Fig. 5c) or PAOlASRN (Fig. 5d) , modulated IL-8 release from human monocytes. Similar results were obtained for incubation times < 24 h (data not shown). Thus, LPS (a stimulus for IL-8 release) was absent or a minor component in the culture supernates from the early stationary phase. The inhibitory effects on IL-8 release were not due to an increase in trypan blue staining, LDH release or a decrease in mitochondria1 activity. The results of determination of IL-8-specific MRNA expression also showed modulation by components > 50 kDa from PA01 (Fig. 6 ). 
Discussion
P aeruginosa infections play an important role in burns and sepsis as well as in CF [l-31. The pathogenesis of lung injury in CF patients colonised by l? aeruginosa is especially associated with a massive accumulation of neutrophil granulocytes and neutrophil-mediated chronic pulmonary inflammation and destruction [4, 25] . Arachidonic acid metabolites such as leukotriene B4 (LTB4) and 12-hydroxyeicosatetraenoic acid (12-HETE) as well as the cytokine IL-8 are potent chemotactic factors for neutrophils [20, 26, 27] . Although elevated LTB4 levels have been found in the sputum of CF patients, it is now established that IL-8 is probably the main cause of the excessive neutrophil recruitment and activation because of its long lasting effect [8-lo] . It has been shown that PLC induces the chemotactically active LTB4 and 12-HETE [2, 20] . Therefore, the hypothesis that PLC could contribute to inflammation by eliciting IL-8 seemed to be reasonable.
Moreover, the description of two types of I? aeruginosa PLC, one haemolytic and the other non-haemolytic, opened up speculation as to the role of both types of PLC during infection. The present study used human monocytes, the main producer of IL-8.
The data clearly show a stimulating effect of PLC-H on These observations are not in contrast to the pathological picture observed in CF. While there is no doubt that PLC is important in initial I? aeruginosa infection because of inflammatory mediator release (enzymes, histamine, LTB4, oxygen metabolites) the role of l? aeruginosa PLC-H in chronic infection must await further studies. P aeruginosa isolates from CF patients at the chronic infection phase showed a decreased production of specific virulence determinants such as exotoxin A, exoenzyme S, phospholipase C and lipase [4, 71 . However, at present there is no information on the time course of LTB4 or IL-8 production in acute and chronic infection. From these results a pathogenic role may be ascribed to PLC-H at least for the acute phase of l? aeruginosa infection [7, 25] . Previous studies have shown that antibodies to PLC are detected early and at high levels in CF patients [14, 151. It seems unlikely that biologically active l? aeruginosa PLC plays any role in chronic l? aeruginosa infection; however, there is no information about the neutralising capacity of these antibodies. Furthermore, PLC-antibody complexes may damage the host by Fc and complement-mediated pathophysiological reactions. The role of PLC-N for such a versatile pathogen as I? aeruginosa requires further studies.
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